Clinical Trial

JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors

Name: JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors — clinical trial record (NCT07475559)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase I, open-label, multicenter, first-in-human study to evaluate the safety, tolerability, PK/pharmacodynamic (PD) characteristics, and anti-tumor activity of JSKN016HC in subjects with advanced malignant solid tumors.

Trial Details

NCT Number	NCT07475559
Lead Sponsor	Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Conditions	Advanced Solid Tumor Malignancies
Enrollment	42 participants
Start Date	2026-03-01
Primary Completion	2028-07-01 (estimated)
Study Completion	2028-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-16